• home
  • partners
  • contact
  • Uitgaven
  • partners
  • Vacatures
  • Nieuws
  • Agenda
  • Opleidingen
    • Nucleair Radioloog
    • Klinisch fysicus
    • Medisch nucleair werker
    • Ziekenhuisapotheker
    • Radiochemicus
  • Adverteren
  • Redactie
home > Uitgaven > Dec '21. Quantitative-imaging in cardiac transthyretin amyloidosis (I-CARE)

Dec '21. Quantitative-imaging in cardiac transthyretin amyloidosis (I-CARE)

A European multicentre study

Auteur

H.S.A. Tingen, A. Tubben, P. van der Meer, H.L.A. Nienhuis, R.H.J.A. Slart

Vakblad

TvNG

Editie

2021-04, december

Thema

Nederlandse Nucleaire Geneeskunde in Europa


 

Download nu

De PDF wordt automatisch gedownload. Afhankelijk van uw browser of device opent deze zich automatisch of staat in de downloads van uw browser

  • Inhoudsopgave

The I-CARE (quantitative imaging in cardiac transthyretin amyloidosis) project is an international, prospective, multicentre study performed at four centres in three European countries. The aim is to develop a precision medicine tool to guide the diagnosis and monitoring of transthyretin amyloidosis cardiomyopathy (ATTRCM) using [18F]sodiumfluoride (Na[18F] F) PET, a total of one hundred subjects with ATTR-CM will be included. As an extension, a quantitative innervation study (I-NERVE) with Iodine-123 labelled meta-iodobenzylguanidine ([123I]mIBG) will be performed in the UMCG.

Hoofdpartner

Business partners

  • Copyright
  • Algemene voorwaarden
  • Disclaimer
  • Privacy
  • Sitemap
  • Colofon

© Kloosterhof Neer BV